Management of Sepsis A 47-Year-Old Woman With an Indwelling Intravenous Catheter and Sepsis

被引:15
作者
Angus, Derek C. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Ctr, Pittsburgh, PA 15261 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 305卷 / 14期
关键词
CRITICALLY-ILL PATIENTS; INTENSIVE INSULIN THERAPY; 2009 INFLUENZA A(H1N1); CRITICAL-CARE SERVICES; SEPTIC SHOCK; ANTIMICROBIAL THERAPY; INFLAMMATORY MARKERS; MORTALITY; EPIDEMIOLOGY; GUIDELINES;
D O I
10.1001/jama.2011.438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe sepsis is the term used to describe the host response to infection when complicated by acute organ dysfunction. Severe sepsis occurs in more than 750 000 individuals in the United States each year, with a hospital mortality of about 30%. Although the classic presentation is of florid shock with frank hypotension, fever, and elevated white blood cell count, many patients can present with cryptogenic shock (shock without hypotension) with more subtle signs of vital organ compromise. Using the case of Ms C, a 47-year-old woman with short gut syndrome and an indwelling intravenous catheter who developed an episode of severe sepsis secondary to a central line infection, treatment of sepsis is discussed. Management consists of prompt intervention with broad-spectrum antibiotics and fluid resuscitation, even in the absence of hypotension, and institution of a variety of strategies in the emergency setting to prevent development or worsening of vital organ dysfunction. Although advances in understanding the host immune response have fueled considerable interest in immunomodulatory therapy, the role of such agents in clinical practice remains limited and controversial. JAMA. 2011;305(14):1469-1477 www.jama.com
引用
收藏
页码:1469 / 1477
页数:9
相关论文
共 59 条
  • [1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
    Abraham, E
    Reinhart, K
    Opal, S
    Demeyer, I
    Doig, C
    Rodriguez, AL
    Beale, R
    Svoboda, P
    Laterre, PF
    Simon, S
    Light, B
    Spapen, H
    Stone, J
    Seibert, A
    Peckelsen, C
    De Deyne, C
    Postier, R
    Pettilä, V
    Sprung, CL
    Artigas, A
    Percell, SR
    Shu, V
    Zwingelstein, C
    Tobias, J
    Poole, L
    Stolzenbach, JC
    Creasey, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 238 - 247
  • [2] Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
    Abraham, E
    Laterre, P
    Garg, R
    Levy, H
    Talwar, D
    Trzaskoma, BL
    Francois, B
    Guy, JS
    Bruckmann, M
    Rea-Neto, A
    Rossaint, R
    Perrotin, D
    Sablotzki, A
    Arkins, N
    Utterback, BG
    Macias, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) : 1332 - 1341
  • [3] *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801
  • [4] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    Angus, DC
    Linde-Zwirble, WT
    Lidicker, J
    Clermont, G
    Carcillo, J
    Pinsky, MR
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (07) : 1303 - 1310
  • [5] E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis - A randomized controlled trial
    Angus, DC
    Birmingham, MC
    Balk, RA
    Scannon, PJ
    Collins, D
    Kruse, JA
    Graham, DR
    Dedhia, HV
    Homann, S
    MacIntyre, N
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (13): : 1723 - 1730
  • [6] Unraveling severe sepsis - Why did OPTIMIST fail and what's next?
    Angus, DC
    Crowther, MA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 256 - 258
  • [7] Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
    Annane, D
    Sébille, V
    Charpentier, C
    Bollaert, PE
    François, B
    Korach, JM
    Capellier, G
    Cohen, Y
    Azoulay, E
    Troché, G
    Chaumet-Riffaut, P
    Bellissant, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07): : 862 - 871
  • [8] Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults A Systematic Review
    Annane, Djillali
    Bellissant, Eric
    Bollaert, Pierre-Edouard
    Briegel, Josef
    Confalonieri, Marco
    De Gaudio, Raffaele
    Keh, Didier
    Kupfer, Yizhak
    Oppert, Michael
    Meduri, G. Umberto
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (22): : 2362 - 2375
  • [9] Australian New Zealand Clinical Trials Registry, AUSTR RES SEPS EV RA
  • [10] Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413